A new mobile testing van will enable Yale Pathology Labs to bring its high-quality diagnostics and patient-care services to vulnerable populations in five Connecticut counties.
A $500 million federal program designed to accelerate the use of game-changing testing technologies is slated to fund the mobile testing van that Yale Pathology Labs will receive from Flambeau RapidX, one of 25 companies to win major contracts under the program. The van will be fully equipped with instrumentation to perform PCR testing. The anticipated launch date of the new van has not been set.
Although the van will initially be used to provide SalivaDirect® COVID testing to vulnerable populations in New Haven, Fairfield, Hartford, Middlesex, and New London counties, Yale Pathology Labs will work with its partners in those communities to identify other testing needs beyond COVID.
Community partners include the Alliance for Living (New London County), Columbus House, Inc. (Hartford, Middlesex, New Haven, and New London counties), Liberation Programs (Fairfield County), the City of New Haven Department of Public Health, and the APT Foundation (New Haven County).
The Yale Pathology Labs van will provide high-performance testing with results in 24 hours. The federal program funding the YPL van is administered through the National Institutes of Health and designed to close significant gaps in testing capacity exposed by the COVID pandemic.
Throughout the pandemic, Yale Pathology Labs, the Yale School of Public Health, and the SalivaDirect® team have worked together with the state Department of Public Health, the City of New Haven, and community organizations to provide free SalivaDirect® testing to New Haven residents at two city sites.